Bal Pharma Ltd
07 Sep 2026 12:00 AM
Bal Pharma Ltd. allotted warrants to promoter Shailesh Siroya for Rs 84,00,000,
Bal Pharma Ltd. announced the allotment of 10,00,000 warrants on a preferential basis to promoter Mr. Shailesh Siroya, for Rs 8,40,00,000, at an issue price of Rs 84 per warrant. The company received Rs 2,10,00,000, representing 25% of the total amount payable for the warrants, and the allotment was approved by the board on September 7, 2026. Each warrant is convertible into one equity share with a face value of Rs 10 and a premium of Rs 74, and can be exercised within 18 months from the allotment date.
Bal Pharma Ltd
27 Aug 2026 12:00 AM
Bal Pharma Limited announces a Rs. 1.20 per share dividend for fiscal year 2025-26,
Bal Pharma Limited has declared a final dividend of Rs. 1.20 per equity share, equivalent to 12% of the face value, for fiscal year 2025-26, with a record date of September 17, 2026. The company will pay the dividend on or after September 24, 2026, and tax will be deducted at source unless shareholders submit the necessary forms and documentation through MUFG Intime India Private Limited`s online facility or designated email addresses.
Bal Pharma Ltd
06 Aug 2026 12:00 AM
Bal Pharma announces board meeting date,
Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2026.
Bal Pharma Ltd
28 May 2026 12:00 AM
Board of Bal Pharma recommends final dividend,
Bal Pharma announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 1.2 per equity Share (i.e. 12%) , subject to the approval of the shareholders.
Bal Pharma Ltd
28 May 2026 12:00 AM
Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter,
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales84.0881.88 3 311.66303.08 3 OPM %12.579.33 -10.249.75 - PBDT6.284.77 32 17.0114.91 14 PBT3.222.59 24 5.935.14 15 NP3.595.43 -34 6.287.22 -13 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
HSL Mobile App